Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Classificação em ações #31185
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Preço da ação
$0.03808538
Valor de mercado
$14.04M
Variação (1 dia)
-3.57%
Variação (1 ano)
6.63%
País
AU
Negociar BCAL Diagnostics Limited (BDX)

Categoria

Histórico de preços das ações de BCAL Diagnostics Limited (BDX)
Preço de fecho mais alto: $0.04 em 2026-08-01

Preço de fecho mais baixo: $0.15 em 2021-07-01
Histórico de preços das ações da BCAL Diagnostics Limited de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -14.06%
2025 6.49%
2024 -5.30%
2023 59.08%
2022 -54.80%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$591.22 21.26%
US
$200.34 -4.15%
US
$24.23 79.49%
CN
$312.51 93.92%
US
$557.21 -12.64%
US